Welcome to our dedicated page for Electrocore SEC filings (Ticker: ECOR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to electroCore, Inc. (Nasdaq: ECOR) SEC filings, offering a detailed view of how the company reports its activities as a commercial-stage bioelectronic medicine and wellness business. electroCore focuses on non-invasive neuromodulation and bioelectronic technologies, including its gammaCore nVNS and Quell neurostimulator prescription products and its Truvaga and TAC-STIM wellness and performance devices.
Through forms such as the annual report on Form 10-K and quarterly reports on Form 10-Q, investors can review discussions of electroCore’s business, risk factors, financial condition, and operating results. Current reports on Form 8-K, several of which are referenced in the input data, disclose material events including quarterly financial results, private placements of common stock to satisfy specific obligations, and changes in the composition and leadership of the board of directors.
Other filings may cover topics such as stockholder votes on charter amendments, advisory votes on executive compensation, and the appointment of new independent directors or committee members. Together, these documents outline electroCore’s governance practices, capital structure developments, and key financial metrics over time.
On Stock Titan, these SEC filings are updated in near real time as they are posted to EDGAR. AI-powered summaries help explain the contents of lengthy reports, highlight important sections of 10-K and 10-Q filings, and clarify the implications of Form 8-K disclosures. Users can also review insider-related filings such as Form 4, where available, to see reported transactions by directors and officers. This combination of primary documents and AI-generated insights is intended to make electroCore’s regulatory record more accessible to a wide range of readers.
electroCore, Inc. Chief Financial Officer Lev Joshua S. reported new equity awards in the company’s common stock. On January 26, 2026, he acquired 2,889 shares at a price of $0 and a separate 25,000-share award, both held directly.
The 25,000-share award represents restricted stock units that vest in three equal 33% installments on each of the first, second, and third anniversaries of the grant date, subject to continued service. Unvested portions can also vest if he is terminated without cause or resigns for good reason within two years after a change in control, under the company’s Executive Severance Policy. His reported beneficial ownership after these transactions is 49,556 shares, including 21,667 shares tied to previously granted restricted stock units with vesting dates in 2027 and 2028.
electroCore CEO Daniel S. Goldberger reported new equity awards in the company. On January 26, 2026, he acquired 20,375 shares of electroCore common stock at $7.47 per share and received a grant of 26,000 restricted stock units at no cost.
The new restricted stock units vest in three equal installments on the first, second, and third anniversaries of the grant date, subject to continued service, and may also vest upon certain qualifying termination events following a change in control. After these transactions, Goldberger beneficially owned 338,940 shares of electroCore common stock, including shares underlying previously granted restricted stock units with future vesting dates.
electroCore, Inc. reported that it has issued a press release providing a business update, including select unaudited preliminary financial guidance for the fourth quarter and full year ended December 31, 2025. This information is being shared with the market through a press release and an accompanying investor presentation.
The company’s executive officers plan to use an investor presentation, filed as an exhibit, in upcoming meetings with investors and analysts. The preliminary figures are based on management estimates and have not been audited or reviewed by the company’s independent registered public accounting firm, so they may change and any changes could be material. The company emphasizes that these disclosures are being furnished, not filed, which limits certain legal liabilities and keeps the information from automatically becoming part of other SEC filings unless specifically incorporated by reference.
electroCore, Inc. Chief Financial Officer reports stock sale and updated holdings. On 12/04/2025, the CFO sold 2,500 shares of electroCore common stock at a weighted average price of $5.05 per share, in a single reported transaction coded as a sale. After this transaction, the reporting person beneficially owns 21,667 shares of common stock.
These 21,667 shares are issuable under previously granted restricted stock units that vest over time. One grant covers 10,000 shares that are scheduled to vest in three annual installments on January 15 of 2026, 2027 and 2028. A second grant covers 11,667 shares, of which 1,000 have already vested and are eligible for sale, and 10,667 are scheduled to vest in two installments on January 12, 2026 and January 12, 2027. The vesting of these awards depends on the CFO’s continued service and includes provisions for accelerated vesting in certain termination events following a change in control, as defined in the company’s Executive Severance Policy.
electroCore (ECOR) filed a Form 4 for its CFO. On 11/12/2025, the executive sold 2,166 shares of Common Stock at a weighted average price of $6.18, with trade prices ranging from $6.0602 to $6.31. Following the sale, the reporting person beneficially owns 23,667 shares.
This balance includes shares issuable under previously granted RSUs: 10,000 scheduled to vest on January 15, 2026 (3,333), January 15, 2027 (3,333), and January 15, 2028 (3,334); and 13,667 of which 3,000 have vested and 10,667 are set to vest on January 12, 2026 (5,333) and January 12, 2027 (5,334), subject to service and change-in-control provisions.
electroCore (ECOR) reported higher Q3 results but remained unprofitable. Net sales were $8.689 million for the quarter, up from $6.554 million a year ago, driven by prescription devices and wellness products. Gross profit was $7.470 million, offset by operating expenses of $10.354 million, resulting in a net loss of $3.405 million, or $0.40 per share. For the nine months, net sales reached $22.789 million versus $18.136 million.
Liquidity improved with cash, cash equivalents, restricted cash and marketable securities totaling $13.201 million as of September 30, 2025. Long‑term debt stood at $6.526 million after a $7.5 million Avenue term loan bearing at least 12.50% interest, with up to $2.5 million convertible at $8.4625 per share and a potential additional $4.5 million Tranche 2. Stockholders’ equity shifted to a deficit of $1.073 million. Sales to the U.S. Department of Veterans Affairs accounted for 69.9% of Q3 net sales. The company also maintains a $20 million ATM program and a $100 million shelf.
electroCore, Inc. furnished an 8-K stating it issued a press release announcing financial results for the quarter ended September 30, 2025 and providing updated guidance for the fourth quarter and full year 2025.
The press release is attached as Exhibit 99.1. The company notes that, except for information relating to Adjusted EBITDA net loss from operations and its reconciliation to GAAP, the information in Items 2.02 and 9.01, including Exhibit 99.1, is furnished and not deemed filed under the Exchange Act.
electroCore, Inc. filed a resale prospectus registering up to 762,508 shares of common stock for offer and sale by selling stockholders. The registration covers 295,420 Conversion Shares issuable upon conversion of up to $2,500,000 of loan principal at $8.4625 per share, 106,351 Private Placement Shares issued to Avenue in connection with the loan, and 360,737 Private Shares issued in October 2025 private placements. The company is not selling any securities in this prospectus and will not receive proceeds from any resale.
The shares stem from an August 4, 2025 Loan and Security Agreement providing up to $12.0 million in term loans (including a funded $7.5 million tranche) maturing on August 1, 2029, with a minimum interest rate of 12.50% and a conversion right for Avenue tied to the Conversion Shares. Including representative holders, this registration lists, among others, Avenue Venture Opportunities Fund II, L.P. 401,771 and Dentons US LLP 272,108. Shares outstanding were 7,995,903 as of October 2, 2025.
electroCore (ECOR) filed a resale registration covering up to 762,508 shares of common stock. The prospectus permits selling stockholders to resell shares from time to time using various methods at fixed, market, or negotiated prices. The company is not selling any securities in this offering and will not receive proceeds from stockholder sales.
The registered shares include 295,420 Conversion Shares issuable upon conversion of up to $2,500,000 of loan principal at a conversion price of $8.4625 per share, 106,351 Private Placement Shares issued to Avenue in connection with a loan agreement, and 360,737 Private Shares issued in October 2025 private placements at $5.145 per share. The Private Shares were issued in exchange for approximately $1.856 million of legal services. electroCore will bear registration expenses; selling holders will bear any selling commissions.
Common stock trades on Nasdaq as ECOR; the closing price was $5.12 per share on October 2, 2025. Shares outstanding were 7,995,903 as of October 2, 2025.
electroCore, Inc. entered into private securities purchase agreements with institutional and accredited investors, issuing 360,737 shares of common stock at
The shares were used to satisfy outstanding legal fee obligations, so the company received no cash. The unregistered shares were issued in reliance on Section 4(a)(2) and Regulation D, and electroCore agreed to file a registration statement to cover their resale within 90 days after the October 2, 2025 closing.
FAQ
What is the current stock price of Electrocore (ECOR)?
What is the market cap of Electrocore (ECOR)?
